Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors for 3,225,000 shares of common stock.
The offering price is set at $1.20 per share, with expected gross proceeds of approximately $3.9 million.
Maxim Group LLC is the sole placement agent for the offering.
Offer Details
3,225,000 shares of common stock at $1.20 per share, gross proceeds of $3.9 million.
Closing Date
Expected to close on August 15, 2025, subject to customary closing conditions.
Registration Statement
Offering made under an effective shelf registration statement on Form S-3 (File No. 333-289198), declared effective on August 8, 2025.
- The offering provides additional funding for Scienture Holdings to support its pharmaceutical operations and product development.
- Maxim Group LLC's involvement as the placement agent enhances the credibility of the offering.
The Registered Direct Offering signifies Scienture Holdings' strategic move to raise capital and expand its pharmaceutical product offerings, positioning the company for future growth and innovation.